Flunixin Meglumine
Therapeutic Category:
NSAID
Non-selective COX inhibitor; blocks prostaglandin synthesis to reduce inflammation, pain, and fever
Primary Use:
Relief from inflammatory conditions, pain, and fever
Inflammatory states in animals
Target Species:
Dogs, cats, equine, field, milking animals
Status:
Commercial
Monograph:
EP, USP
Regulatory Status:
DMF, CEP
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.